Improved Production Efficiencies of Various Adeno-Associated Virus (AAV) Serotypes and a Novel Universal AAV Titration Method |
Cho, Young-Hwa
(Juseong Gene Therapy R&D Center, Juseong University)
Choi, Ye-Jin (Biologics Research Division, National Institute of Food and Drug Safety Evaluation, KFDA) Yun, Jung-Hee (Juseong Gene Therapy R&D Center, Juseong University) Kim, Nam-Hee (Biologics Research Division, National Institute of Food and Drug Safety Evaluation, KFDA) Choi, Mi-Ra (Biologics Research Division, National Institute of Food and Drug Safety Evaluation, KFDA) Choi, Young-Kook (Juseong Gene Therapy R&D Center, Juseong University) Kim, Kyung-Hee (Juseong Gene Therapy R&D Center, Juseong University) Lee, Young-Ill (School of Engineering, University of Suwon) Lee, Beom-Jun (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University) Park, Kee-Rang (Juseong Gene Therapy R&D Center, Juseong University) |
1 | Atchison, R. W., Casto, B. C. and Hammon, W. M. 1965. Adenovirus-Associated Defective Virus Particles. Science 149, 754-756. DOI |
2 | Aucoin, M. G., Perrier, M. and Kamen, A. A. 2008. Critical assessment of current adeno-associated viral vector production and quantification methods. Biotechnol. Adv. 26, 73-88. DOI |
3 | Bantel-Schaal, U. and zur Hausen, H. 1984. Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 134, 52-63. DOI |
4 | Blouin, V., Brument, N., Toublanc, E., Raimbaud, I., Moullier, P. and Salvetti, A. 2004. Improving rAAV production and purification: towards the definition of a scalable process. J. Gene Med. 6, S223-228. DOI |
5 | Buning, H., Perabo, L., Coutelle, O., Quadt-Humme, S. and Hallek, M. 2008. Recent developments in adeno-associated virus vector technology. J. Gene Med. 10, 717-733. DOI |
6 | Chen, C. and Okayama, H. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7, 2745-2752. |
7 | Cho, Y. H., Park, H., Cho, E. S., Kim, W. J., Kang, B. S., Park, B. Y., Kim, Y. J., Lee, Y. I., Chang, S. I. and Park, K. 2007. A novel way of therapeutic angiogenesis using an adeno-associated virus-mediated angiogenin gene transfer. Exp. Mol. Med. 39, 412-418. DOI ScienceOn |
8 | Clark, K. R., Voulgaropoulou, F., Fraley, D. M. and Johnson, P. R. 1995. Cell lines for the production of recombinant adeno- associated virus. Hum. Gene Ther. 6, 1329-1341. DOI |
9 | Clark, K. R. 2002. Recent advances in recombinant adeno- associated virus vector production. Kidney Int. 61, S9-15. DOI |
10 | Collaco, R. F., Cao, X. and Trempe, J. P. 1999. A helper virus- free packing system for recombinant adeno-associated virus vectors. Gene 238, 397-405. DOI |
11 | Gao, G. P., Wilson, J. M. and Wivel, N. A. 2000. Production of recombinant adeno-associated virus. Adv. Virus Res. 55, 529-543 DOI |
12 | Georg-Fries, B., Biederlack, S., Wolf, J. and zur Hausen, H. 1984. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 134, 64-71. DOI |
13 | Grimm, D., Kern, A., Rittner, K. and Kleinschmidt, J. A. 1998. Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum. Gene Ther. 10, 2745-2760. |
14 | Grimm, D. and Kleinschmidt, J. A. 1999. Progress in adeno- associated virus type 2 vector production: promises and prospects for clinical use. Hum. Gene Ther. 10, 2445-2450. DOI |
15 | Hoggan, M. D., Blacklow, N. R. and Rowe, W. P. 1966. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc. Natl. Acad. Sci. USA 55, 1467-1474. DOI |
16 | Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J., Couto, L. B., McClelland, A., Glader, B., Chew, A. J., Tai, S. J., Herzog, R. W., Arruda, V., Johnson, F., Scallan, C., Skarsgard, E., Flake, A. W. and High, K. A. 2000. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. 24, 257-261. DOI |
17 | Matthews, L. C., Gray, J. T., Gallagher, M. R. and Snyder, R. O. 2002. Recombinant adeno-associated viral vector production using stable packaging and producer cell lines. Methods Enzymol. 346, 393-413. DOI |
18 | Kohlbrenner, E., Aslanidi, G., Nash, K., Shklyaev, S., Campbell-Thompson, M., Byrne, B. J., Snyder, R. O., Muzyczka, N., Warrington, K. H. and Zolotukhin, S. 2005. Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Mol. Ther. 12, 1217-1225. |
19 | Kuck, D., Kern, A. and Kleinschmidt, J. A. 2007. Development of AAV serotype-specific ELISAs using novel monoclonal antibodies. J. Virol. Methods 140, 17-24. DOI |
20 | Le, C. T., Gray, G. C. and Poddar, S. K. 2001. A modified rapid method of nucleic acid isolation from suspension of matured virus: applied in restriction analysis of DNA from an adenovirus prototype strain and a patient isolate. J. Med. Microbiol. 50, 571-574. |
21 | Mayginnes, J. P., Reed, S. E., Berg, H. G., Staley, E. M., Pintel, D. J. and Tullis, G. E. 2006. Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR. J. Virol. Methods 137, 193-204. DOI |
22 | Merten, O. W., Geny-Fiamma, C. and Douar, A. M. 2005. Current issues in adeno-associated viral vector production. Gene Ther. 12, S51-61. DOI ScienceOn |
23 | Park, J. Y., Lim, B. P., Lee, K., Kim, Y. G. and Jo, E. C. 2006. Scalable production of adeno-associated virus type 2 vectors via suspension transfection. Biotechnol. Bioeng. 20, 416-430. |
24 | Parks, W. P., Melnick, J. L., Rongey, R. and Mayor, H. D. 1967. Physical assay and growth cycle studies of a defective adeno-satellite virus. J. Virol. 1, 171-180. |
25 | Urabe, M., Ding, C. and Kotin, R. M. 2002. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 13, 1935-1943. DOI |
26 | Qiao, C., Wang, B., Zhu, X., Li, J. and Xiao, X. 2002. A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packing cell lines. J. Virol. 76, 13015-13027 DOI |
27 | Sommer, J. M., Smith, P. H., Parthasarathy, S., Isaacs, J., Vijay, S., Kieran, J., Powell, S. K., McClelland, A. and Wright, J. F. 2003. Quantification of adeno-associated virus particles and empty capsids by optical density measurement. Mol. Ther. 7, 122-128. DOI |
28 | Transfiguracion, J., Jorio, H., Meghrous, J., Jacob, D. and Kamen, A. 2007. High yield purification of functional baculovirus vectors by size exclusion chromatography. J. Virol. Methods 142, 21-28. DOI |
29 | Urabe, M., Nakakura, T., Xin, K. Q., Obara, Y., Mizukami, H., Kume, A., Kotin, R. M. and Ozawa, K. 2006. Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J. Virol. 80, 1874-1885. DOI |
30 | Veldwijk, M. R., Topaly, J., Laufs, S., Hengge, U. R., Wenz, F., Zeller, W. J. and Fruehauf, S. 2002. Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks. Mol. Ther. 6, 272-278. DOI |
31 | Yun, H. J., Cho, Y. H., Moon, Y., Park, Y. W., Yoon, H. K., Kim, Y. J., Cho, S. H., Lee, Y. I., Kang, B. S., Kim, W. J., Park, K. and Seo, W. 2008. Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2. Exp. Mol. Med. 40, 345-353. DOI ScienceOn |